Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/30/1996CN1134697A Pyrimidine-thloalkyl and alkylether compounds
10/30/1996CN1134696A Substituted 5-ring heterocycles, their preparation and their use
10/30/1996CN1134695A Novel compound having platelet aggregation inhibitor effect
10/30/1996CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
10/30/1996CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM
10/30/1996CN1134668A Multiple unit pharmaceutical preparation containing proton pump inhibitor
10/30/1996CN1134667A Multiple unit pharmaceutical preparation containing proton pump inhibitor
10/30/1996CN1134666A Multiple unit tableted dosage form I
10/30/1996CN1134665A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound
10/30/1996CN1134664A Process for preparing a clodronate preparation
10/30/1996CN1134663A New emulsion formulation
10/30/1996CN1134460A HTFIIIA gent
10/30/1996CN1134423A Adhesion receptor antagonists
10/30/1996CN1134422A Improved process for large-scale production of BMS 180048 and analogs
10/30/1996CN1134421A Substituted thiophenesulfonylureas and-thioureas, processes for their preparation, their use as medicament or diagnostic, and medicament containing them
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134417A 2,8-disubstituted quinazolinones
10/30/1996CN1134415A Substituted benzene sulfone urea, benzenesulfonyl thiourea, its preparing method application of preparation for producing medicine and drugs containing them
10/30/1996CN1134414A Substituted benzene sulfone urea, benzenesulfonyl thiourea its preparation, its application as medicine or diagnostic medicine and drugs containing it
10/30/1996CN1134413A 4-Mercaptobenzoylguanidine derivatives
10/30/1996CN1134279A Use of sertraline to treat cancer patients
10/30/1996CN1134278A Aerosol for preventing and curing pulmonary tuberculosis and its preparing method and synergy method
10/30/1996CN1134277A Cosmetic carrier formed with cholesterine and phospholipid and its producing process
10/30/1996CN1033142C Process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus
10/29/1996US5569786 Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"
10/29/1996US5569768 Angiotensin II antagonists
10/29/1996US5569764 N-benzyl dihydroindole LTD4 antagonists
10/29/1996US5569760 Reacting 2-chloro-n-/2-chloro-4-methyl-3-pyridyl/-3-pyridine carboxamide with cyclopropylamine in presence of oxide or hydroxide of group 2 element, cyclizing product
10/29/1996US5569759 Water soluble texaphyrin metal complex preparation
10/29/1996US5569680 Administering to inhibit the production of interleukin-8 in intestinal epithelial cells
10/29/1996US5569679 Instilling a solution of dimethylsulfone dissolved in water intranasally within patients nasal cavity
10/29/1996US5569678 Administering a calcium antagonist to scar site for a time period sufficient to cause extracellular matrix degradation
10/29/1996US5569676 Method for the treatment of osteoarthritis
10/29/1996US5569675 Administering to treat blood disorders
10/29/1996US5569674 Heteroacetic acid derivatives
10/29/1996US5569672 Human and animal growth promoters; calcium pseudomonate
10/29/1996US5569671 Fungicidally active compounds
10/29/1996US5569670 Combination medications containing alpha-lipoic acid and related
10/29/1996US5569669 Treating anxiety, depression
10/29/1996US5569667 Treatment of prostate cancer
10/29/1996US5569666 Administering vibriobactin or parabactin to inhibit proliferation of malignant cells by complexing iron to interfere with their mechanism for iron acquisition
10/29/1996US5569665 Peptidyl derivatives and their use as metalloproteinases inhibitors
10/29/1996US5569663 Use of a spin trap in a cosmetic or dermatological composition
10/29/1996US5569661 Process for the production of b-carbolines
10/29/1996US5569659 4-arylpiperazines and 4-arylpiperidines
10/29/1996US5569658 Tricyclic derivatives
10/29/1996US5569657 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
10/29/1996US5569655 Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
10/29/1996US5569654 Benzodiazepinones
10/29/1996US5569653 N-[(4-(heteroaryl)-1-pyrrolidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
10/29/1996US5569652 For treatment of menopause disorders; oral contraceptives
10/29/1996US5569651 Gentle anti-acne composition
10/29/1996US5569649 Administering a rooperol-like compound
10/29/1996US5569648 Administering insulin-like growth factor
10/29/1996US5569646 Treatment of pneumonia; microbiocides, fungicides
10/29/1996US5569593 Inducing root formation from pilocarpus genus plant
10/29/1996US5569530 X-rays
10/29/1996US5569471 Medicine for the treatment of tumor
10/29/1996US5569457 Administering a betaine compound with influenza vaccine
10/29/1996US5569452 Pharmaceutical formulation having enhanced bile acid binding affinity
10/29/1996US5569451 Photoprotective/cosmetic compositions comprising triorganosilylated benzotriazoles
10/29/1996US5569450 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
10/29/1996CA2175115A1 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/29/1996CA2084750C Method for repelling insects
10/29/1996CA2073873C Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
10/29/1996CA2063727C Method of preventing graft rejection in solid organ transplantation
10/29/1996CA2057912C (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives
10/29/1996CA2053863C Pyridazinone derivatives
10/29/1996CA1338683C Fatty acid therapy and compositions
10/28/1996CA2174892A1 Cyclohexane compounds; process for preparing the same and pharmaceutical compositions containing them
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996033200A1 Novel compounds and methods for therapy
10/24/1996WO1996033198A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/24/1996WO1996033197A1 Preparation of clavulanate salts
10/24/1996WO1996033196A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/24/1996WO1996033195A1 FUSED IMIDAZO[1,2-a]PYRIDINES
10/24/1996WO1996033194A1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
10/24/1996WO1996033193A1 Novel triazolones as apolipoprotein-b synthesis inhibitors
10/24/1996WO1996033192A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex
10/24/1996WO1996033191A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex
10/24/1996WO1996033187A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033186A1 Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
10/24/1996WO1996033185A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996WO1996033184A1 Thf-containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033181A1 Ethynylthiazole derivative
10/24/1996WO1996033177A1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
10/24/1996WO1996033176A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996WO1996033175A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996WO1996033174A1 New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/24/1996WO1996033169A1 1-[φ-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996WO1996033155A1 Fatty acid derivatives
1 ... 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 ... 7860